Diabetologia

, 40:B68 | Cite as

Growth factors and diabetic nephropathy: Kidney structure and therapeutic interventions

  • R. W. Bilous
  • P. Fioretto
  • P. Czernichow
  • K. Drummond
Article

Keywords

Diabetic Nephropathy Captopril Glycaemic Control IDDM Patient Renal Artery Disease 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Mauer M, Mogensen CE, Friedman E (1996) Diabetic nephropathy. In: Schrier RW, Gottschalk CW (eds) Diseases of the kidney, 6th edn. Little Brown & Co. Vol 3, pp 2019–2062Google Scholar
  2. 2.
    Fioretto P, Steffes MW, Mauer M (1994) Glomerular structure in nonproteinuric IDDM patients with various levels of albuminuria. Diabetes 43: 1358–1364CrossRefPubMedGoogle Scholar
  3. 3.
    Steffes MW, Tamborlane W, Becker D, Palmer J, Cleary P for the DCCT Research Group (1996) The effect of intensive diabetes treatment on residual beta cell function in the Diabetes Control and Complications Trial (DCCT). Diabetes 46[Suppl 2]: 18A (Abstract)Google Scholar
  4. 4.
    Krolewski AS, Laffel LMB, Krolewski M, Quinn M, Warram JH (1995) Glycosylated hemoglobin and the risk of microalbuminuria in patients with insulin-dependent diabetes mellitus. N Engl J Med 332: 1251–1255CrossRefPubMedGoogle Scholar
  5. 5.
    The Diabetes Control and Complications (DCCT) Research Group (1995) Effect of intensive therapy on the development and progression of diabetic nephropathy in the Diabetes Control and Complications Trial. Kidney Int 47: 1703–1720CrossRefGoogle Scholar
  6. 6.
    Ohkubo Y, Kishikawa H, Araki E et al. (1995) Intensive insulin therapy prevents the progression of diabetic complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6 year study. Diabetes Res Clin Pract 28: 103–117CrossRefPubMedGoogle Scholar
  7. 7.
    Bilous RW (1996) Early diagnosis of diabetic nephropathy. Diabet Metab Rev 12: 243–253CrossRefGoogle Scholar
  8. 8.
    Microalbuminuria Captopril Study Group (1996) Captopril reduces the risk of nephropathy in insulin-dependent diabetic patients with microalbuminuria. Diabetologia 39: 587–593CrossRefGoogle Scholar
  9. 9.
    Mogensen CE, Keane WF, Bennett PH et al. (1995) Prevention of diabetic renal disease with special reference to microalbuminuria. Lancet 346: 1080–1084CrossRefPubMedGoogle Scholar
  10. 10.
    Lewis EJ, Hunsicker LG, Bain RP, Rohde R for the Collaborative Study Group (1993) The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. N Engl J Med 329: 1456–1462CrossRefPubMedGoogle Scholar
  11. 11.
    Pedrini MT, Levey AS, Lau J, Chalmers TC, Wang PH (1996) The effect of dietary protein restriction on the progression of diabetic and non-diabetic renal diseases: a meta analysis. Ann Int Med 124: 627–632PubMedGoogle Scholar

Copyright information

© Springer-Verlag 1997

Authors and Affiliations

  • R. W. Bilous
    • 1
  • P. Fioretto
    • 2
  • P. Czernichow
    • 3
  • K. Drummond
    • 4
  1. 1.Department of MedicineUniversity of Newcastle upon TyneUK
  2. 2.Department of Internal MedicineUniversity of PadovaItaly
  3. 3.Hopital Robert DebreParisFrance
  4. 4.Montreal Children’s HospitalMontrealCanada

Personalised recommendations